# Melphalan in Patients With Neoplastic Meningitis

> **NCT00002750** · PHASE1 · COMPLETED · sponsor: **Duke University** · enrollment: 6 (estimated)

## Conditions studied

- Brain and Central Nervous System Tumors
- Extragonadal Germ Cell Tumor
- Leukemia
- Lymphoma
- Ovarian Cancer

## Interventions

- **DRUG:** melphalan

## Key facts

- **NCT ID:** NCT00002750
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1992-12
- **Primary completion:** 2001-05
- **Final completion:** 2001-05
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2013-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002750, "Melphalan in Patients With Neoplastic Meningitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00002750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*